Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Diagnostic Accuracy of a Point-of-Care Test for Celiac Disease Antibody Screening among Infertile Patients.

Grode L, Møller Jensen T, Parkner T, Agerholm IE, Humaidan P, Hammer Bech B, Ramlau-Hansen C.

Inflamm Intest Dis. 2019 Aug;4(3):123-130. doi: 10.1159/000501520. Epub 2019 Jul 23.

PMID:
31559264
2.

Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus Vaccine.

Gogesch P, Penner I, Krauter S, Büscher N, Grode L, Aydin I, Plachter B.

Vaccines (Basel). 2019 Sep 1;7(3). pii: E104. doi: 10.3390/vaccines7030104.

3.

Unrecognised coeliac disease among men and women undergoing fertility treatment: A screening study.

Grode LB, Agerholm IE, Humaidan P, Parkner T, Bech BH, Ramlau-Hansen CH, Jensen TM.

United European Gastroenterol J. 2018 Dec;6(10):1477-1484. doi: 10.1177/2050640618796750. Epub 2018 Aug 24.

4.

Reproductive life in women with celiac disease; a nationwide, population-based matched cohort study.

Grode L, Bech BH, Plana-Ripoll O, Bliddal M, Agerholm IE, Humaidan P, Ramlau-Hansen CH.

Hum Reprod. 2018 Jun 15. doi: 10.1093/humrep/dey214. [Epub ahead of print]

PMID:
29912336
5.

Prevalence, incidence, and autoimmune comorbidities of celiac disease: a nation-wide, population-based study in Denmark from 1977 to 2016.

Grode L, Bech BH, Jensen TM, Humaidan P, Agerholm IE, Plana-Ripoll O, Ramlau-Hansen CH.

Eur J Gastroenterol Hepatol. 2018 Jan;30(1):83-91. doi: 10.1097/MEG.0000000000000992.

PMID:
29076940
6.

The Recombinant Bacille Calmette-Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing.

Nieuwenhuizen NE, Kulkarni PS, Shaligram U, Cotton MF, Rentsch CA, Eisele B, Grode L, Kaufmann SHE.

Front Immunol. 2017 Sep 19;8:1147. doi: 10.3389/fimmu.2017.01147. eCollection 2017. Review.

7.

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.

Loxton AG, Knaul JK, Grode L, Gutschmidt A, Meller C, Eisele B, Johnstone H, van der Spuy G, Maertzdorf J, Kaufmann SHE, Hesseling AC, Walzl G, Cotton MF.

Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00439-16. doi: 10.1128/CVI.00439-16. Print 2017 Feb.

8.

A recovery program to improve quality of life, sense of coherence and psychological health in ICU survivors: a multicenter randomized controlled trial, the RAPIT study.

Jensen JF, Egerod I, Bestle MH, Christensen DF, Elklit A, Hansen RL, Knudsen H, Grode LB, Overgaard D.

Intensive Care Med. 2016 Nov;42(11):1733-1743. Epub 2016 Sep 30.

PMID:
27695894
9.

Improvement of nutritional care after colon surgery: the impact of early oral nutrition in the postanesthesia care unit.

Grode LB, Søgaard A.

J Perianesth Nurs. 2014 Aug;29(4):266-74. doi: 10.1016/j.jopan.2013.09.009.

PMID:
25062570
10.

The BCG replacement vaccine VPM1002: from drawing board to clinical trial.

Kaufmann SH, Cotton MF, Eisele B, Gengenbacher M, Grode L, Hesseling AC, Walzl G.

Expert Rev Vaccines. 2014 May;13(5):619-30. doi: 10.1586/14760584.2014.905746. Epub 2014 Apr 7. Review.

PMID:
24702486
11.

Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial.

Grode L, Ganoza CA, Brohm C, Weiner J 3rd, Eisele B, Kaufmann SH.

Vaccine. 2013 Feb 18;31(9):1340-8. doi: 10.1016/j.vaccine.2012.12.053. Epub 2013 Jan 3.

PMID:
23290835
12.

Nonclinical Development of BCG Replacement Vaccine Candidates.

Velmurugan K, Grode L, Chang R, Fitzpatrick M, Laddy D, Hokey D, Derrick S, Morris S, McCown D, Kidd R, Gengenbacher M, Eisele B, Kaufmann SH, Fulkerson J, Brennan MJ.

Vaccines (Basel). 2013 Apr 16;1(2):120-38. doi: 10.3390/vaccines1020120.

13.

Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses.

Desel C, Dorhoi A, Bandermann S, Grode L, Eisele B, Kaufmann SH.

J Infect Dis. 2011 Nov 15;204(10):1573-84. doi: 10.1093/infdis/jir592. Epub 2011 Sep 20.

14.

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Walker KB, Brennan MJ, Ho MM, Eskola J, Thiry G, Sadoff J, Dobbelaer R, Grode L, Liu MA, Fruth U, Lambert PH.

Vaccine. 2010 Mar 8;28(11):2259-70. doi: 10.1016/j.vaccine.2009.12.083. Epub 2010 Jan 20. Review.

PMID:
20074686
15.

Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis.

Rachman H, Strong M, Ulrichs T, Grode L, Schuchhardt J, Mollenkopf H, Kosmiadi GA, Eisenberg D, Kaufmann SH.

Infect Immun. 2006 Feb;74(2):1233-42.

16.

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Eddine A, Mann P, Goosmann C, Bandermann S, Smith D, Bancroft GJ, Reyrat JM, van Soolingen D, Raupach B, Kaufmann SH.

J Clin Invest. 2005 Sep;115(9):2472-9. Epub 2005 Aug 18.

17.

Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.

Oster CG, Kim N, Grode L, Barbu-Tudoran L, Schaper AK, Kaufmann SH, Kissel T.

J Control Release. 2005 May 18;104(2):359-77. Epub 2005 Apr 15.

PMID:
15907586
18.

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.

Williams A, Hatch GJ, Clark SO, Gooch KE, Hatch KA, Hall GA, Huygen K, Ottenhoff TH, Franken KL, Andersen P, Doherty TM, Kaufmann SH, Grode L, Seiler P, Martin C, Gicquel B, Cole ST, Brodin P, Pym AS, Dalemans W, Cohen J, Lobet Y, Goonetilleke N, McShane H, Hill A, Parish T, Smith D, Stoker NG, Lowrie DB, Källenius G, Svenson S, Pawlowski A, Blake K, Marsh PD.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):29-38. Epub 2005 Jan 20.

PMID:
15687025
19.

Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis.

Doherty TM, Olsen AW, Weischenfeldt J, Huygen K, D'Souza S, Kondratieva TK, Yeremeev VV, Apt AS, Raupach B, Grode L, Kaufmann S, Andersen P.

J Infect Dis. 2004 Dec 15;190(12):2146-53. Epub 2004 Nov 8.

PMID:
15551213
20.

Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.

Mollenkopf HJ, Grode L, Mattow J, Stein M, Mann P, Knapp B, Ulmer J, Kaufmann SH.

Infect Immun. 2004 Nov;72(11):6471-9.

21.

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles.

Mollenkopf HJ, Dietrich G, Fensterle J, Grode L, Diehl KD, Knapp B, Singh M, O'Hagan DT, Ulmer JB, Kaufmann SH.

Vaccine. 2004 Jul 29;22(21-22):2690-5.

PMID:
15309815
22.
23.

Mycobacterial proteomes.

Mollenkopf HJ, Mattow J, Schaible UE, Grode L, Kaufmann SH, Jungblut PR.

Methods Enzymol. 2002;358:242-56. No abstract available.

PMID:
12474391
24.

Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium.

Koebernick H, Grode L, David JR, Rohde W, Rolph MS, Mittrücker HW, Kaufmann SH.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13681-6. Epub 2002 Sep 23.

26.

Limited mycobacterial infection of the liver as a consequence of its microanatomical structure causing restriction of mycobacterial growth to professional phagocytes.

Seiler P, Schwendener RA, Bandermann S, Brinkmann V, Grode L, Kaufmann SH, Aichele P.

Infect Immun. 2001 Dec;69(12):7922-6.

28.

Recombinant attenuated bacteria for the delivery of subunit vaccines.

Gentschev I, Dietrich G, Spreng S, Kolb-Mäurer A, Brinkmann V, Grode L, Hess J, Kaufmann SH, Goebel W.

Vaccine. 2001 Mar 21;19(17-19):2621-8.

PMID:
11257401
29.

Secretion of different listeriolysin cognates by recombinant attenuated Salmonella typhimurium: superior efficacy of haemolytic over non-haemolytic constructs after oral vaccination.

Hess J, Grode L, Gentschev I, Fensterle J, Dietrich G, Goebel W, Kaufmann SH.

Microbes Infect. 2000 Dec;2(15):1799-806.

PMID:
11165923
30.

Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG.

Hess J, Grode L, Hellwig J, Conradt P, Gentschev I, Goebel W, Ladel C, Kaufmann SH.

FEMS Immunol Med Microbiol. 2000 Apr;27(4):283-9.

31.

Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun.

Fensterle J, Grode L, Hess J, Kaufmann SH.

J Immunol. 1999 Oct 15;163(8):4510-8.

Supplemental Content

Support Center